Offering

UK College of Medicine offering precision nutrition and culinary elective medicine to medical students

UK College of Medicine offering precision nutrition and culinary elective medicine to medical students

By Lindsay TravisUniversity of Kentucky “For some reason I really wanted fruit or salty foods when I was in treatment. Spicy, salty, salty foods — it helped keep my appetite,” recalls Yueming “Ronnie” Wu, a graduate student in chemistry at the University of Kentucky. In 2020, he was diagnosed with advanced colorectal cancer at the …

UK College of Medicine offering precision nutrition and culinary elective medicine to medical students Read More »

One year after $3 billion mega-merger, Headspace and Ginger launch 'unified' behavioral health offering

One year after $3 billion mega-merger, Headspace and Ginger launch ‘unified’ behavioral health offering

One year after their $3 billion mega-merger, Headspace and Ginger launch new ‘unified’ behavioral health offering Headspace Health is rolling out a unified corporate mental health and wellness offering for its members. The rollout comes about a year after digital mental health companies Headspace and Ginger completed their $3 billion merger. Through this new initiative, …

One year after $3 billion mega-merger, Headspace and Ginger launch ‘unified’ behavioral health offering Read More »

QC Kinetix (Warwick) is a pain control clinic offering sports medicine treatments using regenerative medicine

QC Kinetix (Warwick) is a pain control clinic offering sports medicine treatments using regenerative medicine

Warwick, RI – (NewMediaWire) – November 15, 2022 – via QC Kinetic – Pain is quite a common occurrence in sports, hobbies and careers. Many injuries cause mild, easily manageable discomfort. However, serious injuries are persistent and require more serious interventions such as the prescription of potentially addictive painkillers and recommendations for surgery. Patients often …

QC Kinetix (Warwick) is a pain control clinic offering sports medicine treatments using regenerative medicine Read More »

Clearmind Medicine Announces Price of US$7.5 Million Public Offering and Listing on Nasdaq Capital Markets

Clearmind Medicine Announces Price of US$7.5 Million Public Offering and Listing on Nasdaq Capital Markets

VANCOUVER, Nov. 14, 2022 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq and CSE: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a biotechnology company focused on the discovery and development of new psychedelic-derived therapies to address important under-treated health conditions, today announced the price of its underwritten public offering of 1,153,847 common shares at a public …

Clearmind Medicine Announces Price of US$7.5 Million Public Offering and Listing on Nasdaq Capital Markets Read More »